Wall Street brokerages forecast that HCA Healthcare Inc (NYSE:HCA) will announce earnings per share (EPS) of $1.93 for the current fiscal quarter, Zacks reports. Eleven analysts have provided estimates for HCA Healthcare’s earnings, with the lowest EPS estimate coming in at $1.80 and the highest estimate coming in at $2.09. HCA Healthcare reported earnings of $1.21 per share during the same quarter last year, which would suggest a positive year-over-year growth rate of 59.5%. The business is scheduled to report its next quarterly earnings results on Tuesday, October 30th.

On average, analysts expect that HCA Healthcare will report full-year earnings of $9.23 per share for the current fiscal year, with EPS estimates ranging from $9.07 to $9.32. For the next fiscal year, analysts anticipate that the business will post earnings of $9.93 per share, with EPS estimates ranging from $9.39 to $10.66. Zacks Investment Research’s earnings per share averages are an average based on a survey of analysts that that provide coverage for HCA Healthcare.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Wednesday, July 25th. The company reported $2.29 EPS for the quarter, beating the consensus estimate of $2.16 by $0.13. HCA Healthcare had a negative return on equity of 61.68% and a net margin of 6.21%. The company had revenue of $11.53 billion for the quarter, compared to analyst estimates of $11.32 billion. During the same quarter in the prior year, the company earned $1.73 EPS. The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year.

Several equities research analysts recently commented on the company. Mizuho restated a “buy” rating and set a $145.00 target price on shares of HCA Healthcare in a research report on Thursday, August 2nd. ValuEngine upgraded HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Wednesday, July 18th. Barclays assumed coverage on HCA Healthcare in a research report on Tuesday, August 14th. They set an “overweight” rating and a $150.00 target price on the stock. Jefferies Financial Group restated a “buy” rating and set a $135.00 target price on shares of HCA Healthcare in a research report on Thursday, July 26th. Finally, Credit Suisse Group upped their target price on HCA Healthcare from $122.00 to $143.00 and gave the company an “outperform” rating in a research report on Friday, July 27th. Two research analysts have rated the stock with a sell rating, six have given a hold rating and eighteen have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $126.33.

Shares of HCA Healthcare stock traded down $0.71 on Wednesday, hitting $131.07. 55,873 shares of the company’s stock traded hands, compared to its average volume of 1,929,051. HCA Healthcare has a one year low of $71.18 and a one year high of $138.18. The company has a debt-to-equity ratio of -7.64, a current ratio of 1.36 and a quick ratio of 1.15. The firm has a market cap of $45.84 billion, a price-to-earnings ratio of 19.89, a PEG ratio of 1.20 and a beta of 0.53.

The company also recently declared a quarterly dividend, which will be paid on Friday, September 28th. Shareholders of record on Tuesday, September 4th will be issued a $0.35 dividend. The ex-dividend date of this dividend is Friday, August 31st. This represents a $1.40 annualized dividend and a yield of 1.07%. HCA Healthcare’s payout ratio is currently 21.24%.

In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,689 shares of the stock in a transaction that occurred on Wednesday, July 25th. The stock was sold at an average price of $112.53, for a total value of $190,063.17. Following the transaction, the senior vice president now owns 10,057 shares in the company, valued at $1,131,714.21. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Jonathan B. Perlin sold 12,500 shares of the stock in a transaction that occurred on Thursday, June 21st. The stock was sold at an average price of $108.00, for a total value of $1,350,000.00. Following the completion of the transaction, the insider now owns 107,894 shares in the company, valued at approximately $11,652,552. The disclosure for this sale can be found here. In the last quarter, insiders sold 182,757 shares of company stock worth $22,468,053. Corporate insiders own 2.80% of the company’s stock.

Institutional investors have recently modified their holdings of the company. Smithfield Trust Co. raised its stake in shares of HCA Healthcare by 541.9% in the second quarter. Smithfield Trust Co. now owns 995 shares of the company’s stock worth $102,000 after purchasing an additional 840 shares during the last quarter. Signet Financial Management LLC purchased a new stake in shares of HCA Healthcare in the second quarter worth approximately $137,000. Adviser Investments LLC purchased a new stake in shares of HCA Healthcare in the second quarter worth approximately $159,000. Bridgeworth LLC purchased a new stake in shares of HCA Healthcare in the second quarter worth approximately $173,000. Finally, Hyman Charles D purchased a new stake in shares of HCA Healthcare in the second quarter worth approximately $205,000. 70.40% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Article: Calculate Your Return on Investment (ROI)

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.